|Cases, 2015||Globally: 214 million
(uncertainty range: 149 – 303 million)
|Deaths, 2015||Globally: 438 000
(uncertainty range: 236 000 – 635 000)
91% of all malaria deaths occur in sub-Saharan Africa
|Population at risk||3.2 billion (half of the world population)|
|Affected countries||In 2015, 97 countries and territories had on-going malaria transmission.|
|Progress||The malaria mortality rate was reduced in 2000 – 2015
Globally: by 60% and by 65% among children under 5 since 2000On the basis of reported cases for 2013, 55 countries are on track to reduce their malaria
case incidence rates by 75%, in line with World Health Assembly and Roll Back Malaria targets for 2015.In 2014 an increasing number of countries are on the verge of eliminating malaria 13 countries reported zero cases of the disease and 6 countries reported fewer than 10 cases. The fastest decreases were seen in the Caucasus and Central Asia (which reported zero cases of malaria in 2014) and in Eastern Asia.
|Impact||Between 2000 and 2015, an estimated 6.2 million lives were saved as a result of a scale-up
of malaria interventions. Around 5.9 million of these lives saved are in the under-five age group.
|Required health expenditure||By 2020, we need to be mobilizing US$6.4 billion per year.
In 2015, the global total of international and domestic funding for malaria was US$ 2.7 billion – less than half of what is needed.
To achieve the new global goals (GTS and AIM) for a malaria free-world, annual funding for malaria needs to triple over the next 15-year period, from US$ 2.7 billion (current spending) to US$ 8.7billion (2030).
|Economic cost||Direct: USD 12 billion per year in direct losses,
lost 1.3% of GDP growth per year for Africa.
|Current level of coverage||Treatment: In 2013, 392 million artemisinin-based combination therapies (ACTs) were procured by the public and private sectors in endemic countries – up from 278 million in 2011, and just 11 million in 2005.
Since 2000, the use of ACTs for the treatment of fever in children has risen steadily. However, in 2015, only 13% of children with fever in sub-Saharan Africa received an ACT.Nets: in 2014, an estimated 214 million long-lasting insecticidal nets (LLINs) were delivered to endemic countries, a major increase over the 70 million bed nets that were delivered in 2012.IRS (indoor residual spraying): in 2013, 123 million people (3.5% of the global population at risk of malaria) were protected by indoor residual spraying worldwide. In 2015, an estimated 7% of children at risk of malaria in sub-Saharan Africa lived in a household protected by IRS. However, 25% of children in this region still live in a household with no ITN and no protection provided by IRS.Diagnostics: The volume of RDT sales to the public and private sectors of endemic countries has increased from 88 million in 2010 to 319 million in 2013. The number of patients tested by microscopic examination increased to 197 million in 2013, with India accounting for over 120 million slide examinations. But, in 2015, most children suspected of having malaria did not receive a diagnostic test.